Yttrium-90 is now commonly used in the knee because of its favourable physical properties, having a short half life (2-7 days), emitting high energy , particles (Emax 2-3 MeV), and lacking y rays.
Radioactive colloids have been used to treat chronic synovitis for more than 20 years. Various radionuclides have been used in a range of joints for this purpose, including 9y, 169Er, 186Re, and 198Au.
Yttrium-90 is now commonly used in the knee because of its favourable physical properties, having a short half life (2-7 days), emitting high energy , particles (Emax 2-3 MeV), and lacking y rays.
The presence of a Baker's cyst has been considered an adverse factor when predicting the success of intra-articular radiotherapy to the knee joint. Davis and Jayson described two cases of joint rupture one to two months after 9"Y injection and suggested that this was an important hazard.2 Quadriceps contraction normally produces subatmospheric or small positive pressures within the knee, but in the presence of arthritis high positive pressures are developed; this is enhanced by an effusion. substantial proportion of the administered radioactivity after 90Y treatment to be diverted from the knee joint to the cyst, thereby diminishing the therapeutic effect on the knee synovium.7 8 In this study the Leakage of (Y from the knee was monitored by estimation of liver radioactivity at 46 hours in eight patients and of lymph node radioactivity in one patient showing uptake in the groin. Table 1 shows the serial estimates of the 93Y content of cysts in the 10 patients, normalised as a percentage of the administered activity, which were obtained using estimated cyst volumes and calibration factors interpolated from phantom measurements. Table 1 also includes an index of the size of the Baker's cysts for comparison with estimated uptakes. This index was estimated from arthrograms as the product of the maximum vertical and horizontal dimensions (cm) of the two dimensional image of the cyst, and cysts were graded according to whether this index was less than 20, between 20 and 40, or greater than 40.
Uptake of "'Y in cysts was very variable, ranging from 0 to about 40% of administered radioactivity with a mean value of 9-4%. Apart from the single high value of 40%, however, uptake in the remaining nine patients did not exceed 20% with a mean value of 6-3%. Figs la and b show a single sagittal slice through the knee of the patient who had the highest cyst uptake in relation to the arthrogram, and Fig. 2 shows the result of a three dimensional reconstruction of tomographic data for the same patient. In some cases retention in cysts remained (Figs 3a, b, and c) , but none penetrated into the calf cyst, which is clearly shown in the CT slice (Fig. 3d) When the single high uptake value of 40% is excluded the mean uptake in the remaining nine patients was only about 6% of the injected -(Y. This probably leads to an insignificant modification of the therapeutic effect, particularly in view of the difficulties in the estimation of radiation dose resulting from our imprecise knowledge of the actual surface area of synovial membrane, and the spatial relationship between 9"Y particles and the cells of the membrane. It is evident that in a small proportion of patients there is substantial uptake in cysts, which may be sufficient to reduce the therapeutic effect significantly, leading to an unsatisfactory response; after follow up in such cases further 90Y treatment may be judged to be necessary. The patient in our series with highest cyst uptake (patient No 2) showed little improvement in the degree of synovitis up to one year after treatment, but, in general, clinical response showed poor correlation with uptake of 9'Y in cysts (Table 1) . For example, poor clinical response was also observed in two patients (3 and 7) who had no measurable cyst uptake. Furthermore, while two patients (4 and 10) with low uptakes showed good or excellent response, a good response was also observed in patient 6 who had the second highest cyst uptake. Because the uptake in cysts is not predictable from the apparent size and filling of cysts on arthrograms we are unable to suggest the expedient of injecting more radioactivity at the first injection.
The use of a computer program to produce three dimensional images of the knee of one of our patients suggests that the application of this technique has significant value in improving subjective visualisation of the distribution of 90Y in the knee.
The example in Fig. 2 shows one of 64 different views around the longitudinal axis of the patient, allowing examination of the distribution from all aspects. The size, shape, and location of the cyst can be appreciated more clearly than from separate transaxial, sagittal, or coronal slices, suggesting a complementary role for this technique, particularly in cases of marginal or equivocal cyst uptake.
Monitoring of the uptake of 90Y in liver and lymph nodes has been used to detect leakage from the knee, but the uptake at these sites usually does not fully account for activity apparently lost from the knee.7 In the present studies the mean (SD) retention in knees at 46 hours was 85 (12)% of administered 90Y, whereas the highest combined uptake in liver and lymph nodes was 6%. Spooren et al found no trace of radioactivity in regional lymph glands of 10 patients at 24 or 48 hours after injection of 90Y silicate into the knee joint." Although the residual 90Y released from the knee is presumably generally distributed throughout the body, it is possible that in some cases discrepancies can be partly explained by changes in counting efficiency resulting from observed alterations in distribution of injected 90Y within the knee as suggested by the results of measurements on phantoms.
Redistribution of tY within the knee also emphasises the difficulty of making accurate radiation dose estimates. The wide variation in such estimates was illustrated in a series of 16 knees (11 patients) by Williams, 7 
